SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.35-0.8%Dec 2 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Torben Noerup Nielsen who wrote (15658)2/23/1998 12:30:00 PM
From: Flagrante Delictu  Read Replies (1) of 32384
 
Torben, Re: LGND being "different from the run-of-the mill biotechs" The corporate name, Ligand Pharmaceuticals, seems to point at their aspirations. With a management composed of high ranking operatives from various top pharmas, as well as a stated mission to become a niche pharma in cancer, women's & men's health, metabolic, and now, possibly endocrine & atherosclerotic indications, the hiring of sales & marketing execs loudly proclaims their intention of "going for it" { If you will pardon the expression} . They've done it before with prior employers. They can't wait to do it for themselves { & us}. Godspeed. Bernie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext